ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.002,02
-1,43%
S&P 500
5.431,60
-0,04%
Dow Jones
38.589,16
-0,15%
Euro vs US Dollar
1,07175
-0,05%
Bitcoin
66.223,50
0,33%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. CV Therapeutics (MM) (CVTX)

  7. CV Therapeutics (MM) (CVTX) News

CVTX

CV Therapeutics (CVTX)

CV Therapeutics (MM)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:CVTX
DatumZeitQuelleÜberschriftSymbolFirma
17/04/200923h01Edgar (US Regulatory)Termination of Registration of a Class of Security under Section 12(g) (15-12G)NASDAQ:CVTXCV Therapeutics (MM)
17/04/200922h32Edgar (US Regulatory)(25-NSE)NASDAQ:CVTXCV Therapeutics (MM)
17/04/200922h15Business WireGilead Sciences Completes Acquisition of CV TherapeuticsNASDAQ:CVTXCV Therapeutics (MM)
17/04/200919h29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
17/04/200919h29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
17/04/200919h28Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
17/04/200919h25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
16/04/200923h01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
16/04/200923h00Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
16/04/200922h59Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
16/04/200922h57Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
16/04/200922h56Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
16/04/200922h55Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
15/04/200921h54Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:CVTXCV Therapeutics (MM)
14/04/200912h09Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:CVTXCV Therapeutics (MM)
14/04/200912h06Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:CVTXCV Therapeutics (MM)
13/04/200923h23Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:CVTXCV Therapeutics (MM)
13/04/200923h09Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:CVTXCV Therapeutics (MM)
09/04/200922h53Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:CVTXCV Therapeutics (MM)
09/04/200922h06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
09/04/200922h05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
09/04/200922h05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
09/04/200922h04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
09/04/200922h03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
09/04/200921h11Edgar (US Regulatory)Schedule 13GNASDAQ:CVTXCV Therapeutics (MM)
08/04/200921h27Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:CVTXCV Therapeutics (MM)
08/04/200916h49MarketwiredAnalystChoice.com Free Investment Opinion on PPDI, MEDX, CVTX and OSIPNASDAQ:CVTXCV Therapeutics (MM)
07/04/200901h50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
06/04/200922h12Edgar (US Regulatory)Amended Annual Report (10-K/A)NASDAQ:CVTXCV Therapeutics (MM)
06/04/200920h02Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:CVTXCV Therapeutics (MM)
 Showing the most relevant articles for your search:NASDAQ:CVTX

Kürzlich von Ihnen besucht

TG
A1ZJ57
CNP Assurances
LSE
BN78
City Stock.29
NYSE
SCCU
NYSE
SSW.PRH
Seaspan Corp.
LSE
0M1O
Xpo Logistics
LSE
34WS
Blurb Grp 25
COIN
CTCGBP
NASDAQ
MSFT
Microsoft
BIT
SJPM5L
Societe Generale Effekten
COIN
RPGEUR
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten